{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:02:11Z","timestamp":1781013731269,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007154","name":"Wake Forest University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007154","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Biomarkers that predict neurologic death may allow for personalization of therapy for high-risk brain metastases patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with NSCLC who underwent comprehensive genomic profiling were identified in an institutional database. Neurologic death was determined by medical record review. Proportional hazards regression models considering non-neurologic death as a competing risk were used to identify mutations statistically associated with the occurrence of neurologic death (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.1) and to create a risk scoring system for neurologic death. A competing risk proportional hazards regression model with non-neurologic death as a competing risk was used to assess the association between the risk score and neurologic death, and to calculate hazard ratios predicting neurologic death between risk groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>307 patients were included in the primary analysis and 213 in a cohort of patients with brain metastases. Risk scores were constructed in both populations. Patients with higher risk scores had an increased risk of neurologic death when compared to those in the low-risk group, with respective HRs of 3.76 for the entire cohort and 2.87 for the brain metastasis cohort per unit increase in the risk score. When dividing the risk score into three groups, the cumulative incidence of neurologic death in high, moderate, and low risk groups was 49.0%, 20.3% and 0% for the entire cohort and 52.4%, 30.4%, and 0% in the brain metastasis cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Development of a genomic signature to predict neurologic death via non-invasive liquid biopsy appears feasible in NSCLC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-026-05642-z","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:19:02Z","timestamp":1779725942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-3213","authenticated-orcid":false,"given":"Sarah E.","family":"Glynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"D\u2019Agostino Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"R. Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdulhaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lycan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Jeffrey","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Tatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian W.","family":"Laxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"T. Whitlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corbin A.","family":"Helis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"3","key":"5642_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/neuros\/nyy216","volume":"84","author":"MH Soike","year":"2019","unstructured":"Soike MH, Hughes RT, Farris M, McTyre ER, Cramer CK, Bourland JD et al (2019) Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain. Metastases? Neurosurg 84(3):558\u2013566","journal-title":"Metastases? Neurosurg"},{"issue":"8","key":"5642_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494\u2013500","journal-title":"N Engl J Med"},{"issue":"3","key":"5642_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/cncr.28422","volume":"120","author":"SC Lester","year":"2014","unstructured":"Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr., Ayala-Peacock DN, Randolph DM 2 et al (2014) Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer 120(3):433\u2013441","journal-title":"Cancer"},{"issue":"5","key":"5642_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ijrobp.2015.04.032","volume":"92","author":"JT Lucas Jr","year":"2015","unstructured":"Lucas JT Jr., HGt C, White L, Fitzgerald N, Isom S, Bourland JD et al (2015) Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases? Int J Radiat Oncol Biol Phys 92(5):1008\u20131015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5642_CR5","first-page":"402","volume":"6","author":"CM Lanier","year":"2019","unstructured":"Lanier CM, Hughes R, Ahmed T, LeCompte M, Masters AH, Petty WJ et al (2019) Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract 6(5):402\u2013409","journal-title":"Neurooncol Pract"},{"issue":"22","key":"5642_CR6","doi-asserted-by":"publisher","first-page":"18945","DOI":"10.18632\/oncotarget.4153","volume":"6","author":"AG Johnson","year":"2015","unstructured":"Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT et al (2015) Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget 6(22):18945\u201318955","journal-title":"Oncotarget"},{"issue":"1","key":"5642_CR7","first-page":"vdad031","volume":"5","author":"M Chan","year":"2023","unstructured":"Chan M, Tatter S, Chiang V, Fecci P, Strowd R, Prabhu S et al (2023) Efficacy of laser interstitial thermal therapy for biopsy-proven radiation necrosis in radiographically recurrent brain metastases. Neurooncol Adv 5(1):vdad031","journal-title":"Neurooncol Adv"},{"issue":"3","key":"5642_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11060-018-03008-8","volume":"140","author":"AE Dohm","year":"2018","unstructured":"Dohm AE, Hughes R, Wheless W, Lecompte M, Lanier C, Ruiz J et al (2018) Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases. J Neurooncol 140(3):749\u2013756","journal-title":"J Neurooncol"},{"issue":"2","key":"5642_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(2):134\u2013141","journal-title":"J Clin Oncol"},{"issue":"2","key":"5642_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-017-2588-4","volume":"135","author":"DN Ayala-Peacock","year":"2017","unstructured":"Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C et al (2017) Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram. J Neuro-Oncol 135(2):403\u2013411","journal-title":"J Neuro-Oncol"},{"key":"5642_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.radonc.2019.08.011","volume":"142","author":"ER McTyre","year":"2020","unstructured":"McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR et al (2020) Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiother Oncol 142:168\u2013174","journal-title":"Radiother Oncol"},{"issue":"1","key":"5642_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11060-014-1373-x","volume":"117","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Ellis TL, Lovato JF, Urbanic JJ, Bourland JD, Munley MT et al (2014) Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? J Neurooncol 117(1):167\u2013174","journal-title":"J Neurooncol"},{"key":"5642_CR13","doi-asserted-by":"crossref","unstructured":"Glynn SE, Lanier CM, Choi AR, D\u2019Agostino R Jr., Farris M, Abdulhaleem M et al (2025) Genomic signature for Initial Brain Metastasis Velocity (iBMV) in non-small-cell lung cancer patients: the elusive biomarker to predict the development of brain metastases? Cancers (Basel). 17(6)","DOI":"10.3390\/cancers17060991"},{"key":"5642_CR14","doi-asserted-by":"publisher","first-page":"1214126","DOI":"10.3389\/fonc.2023.1214126","volume":"13","author":"M Abdulhaleem","year":"2023","unstructured":"Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Agostino RJ, Lycan T et al (2023) Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases. Front Oncol 13:1214126","journal-title":"Front Oncol"},{"issue":"4","key":"5642_CR15","first-page":"558","volume":"19","author":"ER McTyre","year":"2017","unstructured":"McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT, Hinson WH et al (2017) Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. Neurooncology 19(4):558\u2013566","journal-title":"Neurooncology"},{"issue":"17","key":"5642_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17):1485\u20131489","journal-title":"JAMA"},{"issue":"15","key":"5642_CR17","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1158\/1078-0432.CCR-19-0624","volume":"25","author":"NB Leighl","year":"2019","unstructured":"Leighl NB, Page RD, Raymond VM, Daniel DB, Divers SG, Reckamp KL et al (2019) Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer. Clin Cancer Res 25(15):4691\u20134700","journal-title":"Clin Cancer Res"},{"issue":"3","key":"5642_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/cam4.82","volume":"2","author":"C Villalva","year":"2013","unstructured":"Villalva C, Duranton-Tanneur V, Guilloteau K, Burel-Vandenbos F, Wager M, Doyen J et al (2013) EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients. Cancer Med 2(3):296\u2013304","journal-title":"Cancer Med"},{"issue":"19","key":"5642_CR19","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1158\/1078-0432.CCR-13-0836","volume":"19","author":"KL Johung","year":"2013","unstructured":"Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S et al (2013) A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res 19(19):5523\u20135532","journal-title":"Clin Cancer Res"},{"issue":"1","key":"5642_CR20","first-page":"vdac186","volume":"5","author":"M Abdulhaleem","year":"2023","unstructured":"Abdulhaleem M, Ruiz J, O\u2019Neill S, Hughes RT, Qasem S, Strowd RE et al (2023) Collagen deposition within brain metastases is associated with leptomeningeal failure after cavity-directed radiosurgery. Neurooncol Adv 5(1):vdac186","journal-title":"Neurooncol Adv"},{"issue":"6","key":"5642_CR21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.wneu.2013.02.025","volume":"82","author":"MT Neal","year":"2014","unstructured":"Neal MT, Chan MD, Lucas JT Jr., Loganathan A, Dillingham C, Pan E et al (2014) Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg 82(6):1250\u20131255","journal-title":"World Neurosurg"},{"issue":"11","key":"5642_CR22","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","volume":"5","author":"PK Brastianos","year":"2015","unstructured":"Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT et al (2015) Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov 5(11):1164\u20131177","journal-title":"Cancer Discov"},{"issue":"10055","key":"5642_CR23","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0140-6736(16)30825-X","volume":"388","author":"P Mulvenna","year":"2016","unstructured":"Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E et al (2016) Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 388(10055):2004\u20132014","journal-title":"Lancet"},{"issue":"2","key":"5642_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/annonc\/mdx740","volume":"29","author":"E McTyre","year":"2018","unstructured":"McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C et al (2018) Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis. Ann Oncol 29(2):497\u2013503","journal-title":"Ann Oncol"},{"issue":"1","key":"5642_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11060-018-03032-8","volume":"141","author":"CK Cramer","year":"2019","unstructured":"Cramer CK, McKee N, Case LD, Chan MD, Cummings TL, Lesser GJ et al (2019) Mild cognitive impairment in long-term brain tumor survivors following brain irradiation. J Neurooncol 141(1):235\u2013244","journal-title":"J Neurooncol"},{"key":"5642_CR26","doi-asserted-by":"publisher","first-page":"615472","DOI":"10.3389\/fonc.2020.615472","volume":"10","author":"J Su","year":"2020","unstructured":"Su J, Song Q, Qasem S, O\u2019Neill S, Lee J, Furdui CM et al (2020) Multi-omics analysis of brain metastasis outcomes following craniotomy. Front Oncol 10:615472","journal-title":"Front Oncol"},{"issue":"Suppl 3","key":"5642_CR27","doi-asserted-by":"publisher","first-page":"S298","DOI":"10.21037\/tlcr.2019.05.15","volume":"8","author":"M Nishino","year":"2019","unstructured":"Nishino M, Soejima K, Mitsudomi T (2019) Brain metastases in oncogene-driven non-small cell lung cancer. Transl Lung Cancer Res 8(Suppl 3):S298\u2013S307","journal-title":"Transl Lung Cancer Res"},{"issue":"30","key":"5642_CR28","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1200\/JCO.23.02668","volume":"42","author":"LRG Pike","year":"2024","unstructured":"Pike LRG, Miao E, Boe LA, Patil T, Imber BS, Myall NJ et al (2024) Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC). J Clin Oncol 42(30):3606\u20133617","journal-title":"J Clin Oncol"},{"key":"5642_CR29","doi-asserted-by":"publisher","first-page":"1364021","DOI":"10.3389\/fendo.2024.1364021","volume":"15","author":"AR Choi","year":"2024","unstructured":"Choi AR, D\u2019Agostino RB Jr., Farris MK, Abdulhaleem M, Hunting JC, Wang Y et al (2024) Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne) 15:1364021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5642_CR30","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/j.ijrobp.2024.07.169","volume":"120","author":"AR Choi","year":"2024","unstructured":"Choi AR, Lanier CM, Glynn SE, D\u2019Agostino R, Farris M, Abdulhaleem M et al (2024) External Validation of Oligometastatic Genomic Signaturein Non-Small Cell Lung Cancer Patients. Int J Radiat Oncol 120(2):S95\u2013S","journal-title":"Int J Radiat Oncol"},{"key":"5642_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clineuro.2018.11.011","volume":"176","author":"RF Shenker","year":"2019","unstructured":"Shenker RF, McTyre ER, Taksler GB, D\u2019Agostino RB, Cramer CK, Ruiz J et al (2019) Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery. Clin Neurol Neurosur 176:10\u201314","journal-title":"Clin Neurol Neurosur"},{"issue":"2","key":"5642_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/cco-21-102","volume":"11","author":"M Abdulhaleem","year":"2022","unstructured":"Abdulhaleem M, Ruiz J, Cramer C, Xing F, Lo HW, Su J et al (2022) Brain metastasis prognostic nomograms and brain metastasis velocity: a narrative review. Chin Clin Oncol 11(2):10","journal-title":"Chin Clin Oncol"},{"issue":"2","key":"5642_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/13696998.2018.1549056","volume":"22","author":"J Signorovitch","year":"2019","unstructured":"Signorovitch J, Zhou Z, Ryan J, Anhorn R, Chawla A (2019) Budget impact analysis of comprehensive genomic profiling in patients with advanced non-small cell lung cancer. J Med Econ 22(2):140\u2013150","journal-title":"J Med Econ"},{"issue":"1","key":"5642_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s42003-023-05124-2","volume":"6","author":"Q Song","year":"2023","unstructured":"Song Q, Ruiz J, Xing F, Lo HW, Craddock L, Pullikuth AK et al (2023) Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment. Commun Biol 6(1):760","journal-title":"Commun Biol"},{"key":"5642_CR35","doi-asserted-by":"crossref","unstructured":"Kalita-de Croft P, Joshi V, Saunus JM, Lakhani SR (2022) Emerging biomarkers for diagnosis, prevention and treatment of brain metastases-from biology to clinical utility. Diseases. 10(1)","DOI":"10.3390\/diseases10010011"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05642-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05642-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:40:30Z","timestamp":1781012430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05642-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5642"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05642-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Wake Forest Health Sciences (IRB00033881 approved 1\/23\/12, renewed 10\/28\/25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics"}},{"value":"Informed Consent Statement: Patient consent was waived due to the retrospective nature of this medical record study because the research posed minimal risk to the subjects, and the findings would not impact their welfare or provide any direct benefit. The study was conducted using de-identified data, to ensure the privacy and confidentiality of all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}